Learn more

ESP FARMACEUTICAS CENTRUM SA

Overview
  • Total Patents
    32
About

ESP FARMACEUTICAS CENTRUM SA has a total of 32 patent applications. Its first patent ever was published in 1979. It filed its patents most often in Spain, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and machines are CMI AG, CORTENDO INVEST AB and METABOLIC PHARMACEUTICALS PTY LTD.

Patent filings per year

Chart showing ESP FARMACEUTICAS CENTRUM SAs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Quintanilla Almagro Eliseo 21
#2 Diaz Alperi Joaquin 9
#3 Martinez Fernandez Antonio 5
#4 Sanchez Andugar Alfonso 4
#5 Claramunt Vallespi Rosa Maria 4
#6 Sempere Ortells Jose Miguel 2
#7 Segura Panos Ana 1
#8 Quintanilla Almagro Elisio 1
#9 Almagro Eliseo Q 1
#10 Merino Jose Ruiz 1

Latest patents

Publication Filing date Title
ES2197018A1 NEW THERAPEUTIC USE OF POLYPODIUM EXTRACTS.
ES2147163A1 A pharmaceutical composition with regulatory activity of the expression of the adhesion molecules.
EP0680762A1 Pharmaceutical composition comprising fern extract(s) for the treatment of neurodegenerative diseases.
ES2088770A1 A pharmaceutical composition with activity in the treatment of cognitive dysfunctions and / or neuroinmunes.
ES2068163A1 Procedure for obtaining a plant extract with activity in the treatment of cognitive dysfunctions and / or neuroinmunes.
ES2008773A6 Bis-pyrazolyl methane derivs. prepn.
ES2008769A6 Di:nitro pyrazolyl methane prepn.
ES2008770A6 Di:nitro tetra:methyl bis-pyrazolyl methane prepn.
ES2008771A6 Di:bromo bis-pyrazolyl methane prepn.
ES2008772A6 Bis-pyrazolyl methane prepn.
ES2010732A6 Di:chloro chlorobenzyl thio-phenethyl imidazole nitrate prepn.
ES2008341A6 Di:methyl nitro-pyrazolyl adamantan-ol prepn.
ES2008340A6 Di:methyl nitro-pyrazolyl adamantan-ol prepn.
ES2008339A6 Cyclohexyl hydroxymethyl pyridone prepn.
ES2007349A6 Di:amino piperidino-pyrimidine oxide prepn.
ES8707504A1 Bis-pyrazolyl methane deriv. prepn.
PT73327A Process for the preparation of sublingual administrable antitetanic vaccine
ES8104719A1 Procedure for the obtaining of new excipients for rectal administration through suppositories (Machine-translation by Google Translate, not legally binding)
ES8104250A1 Procedure for the obtaining of 2-hydroxypropanoate of 2,4-diamino-5 (3,4,5-trimetoxibenzyl) -pirimidine (Machine-translation by Google Translate, not legally binding)
ES484388A1 Synthesis procedure of trimetropin lactate (Machine-translation by Google Translate, not legally binding)